Brief: Bluejay Diagnostics Inc Reports Quarterly Loss Per Share Of $0.15
08/11/2022 23:37
Nov 8 (Reuters) - Bluejay Diagnostics Inc BJDX.O :
* BLUEJAY DIAGNOSTICS INC - CASH AND CASH EQUIVALENTS ON
SEPTEMBER
30, 2022 WERE $13.3 MILLION, AS COMPARED TO $19.0 MILLION ON
DECEMBER 31, 2021
* BLUEJAY DIAGNOSTICS INC- QTRLY LOSS PER SHARE $0.15
Further company coverage: BJDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bluejay Diagnostics
See all newsBrief: Bluejay Diagnostics Announces Successful Completion Of Enrollment In The Symon-II Multicenter Clinical Validation Study
Brief: Bluejay Diagnostics And Argonaut Manufacturing Services Announce Strategic Partnership
Bluejay Diagnostics Q1 net loss unchanged
Brief: Bluejay Diagnostics, Inc. Announces Completion Of 624 Patient Enrollments In Symon-Ii Pivotal Clinical Trial
Brief: Bluejay Diagnostics Provides Corporate Update And 2026 Strategic Outlook